Moreover, 57.1% of patients with severe COVID-19 with comorbidity had greater than 1.5-fold change of FCGR3B compared with 28.1% in controls (Figure 4C, p = 0.01, Figure S13; Table S5). The gene discussed is FCGR3B; the disease is COVID-19.